Charles Schoch
Vermögen: 360 145 $ am 31.05.2026
Vermögen: 360 145 $ am 31.05.2026
Charles Schoch is Chief Financial Officer, Secretary & Treasurer at Candel Therapeutics, Inc. since 2024.
Previously, Mr. Schoch was Controller at Corbus Pharmaceuticals, Inc. from 2020 to 2021.
Education includes undergraduate studies at Elon University and graduate studies including an MBA at Northeastern University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.04.2026 | 43 391 ( 0,06 % ) | 360 145 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Finanzdirektor/CFO | 12.01.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Comptroller/Controller/Auditor | 01.11.2021 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Elon University
Elon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen